Full Schedule

Speaker: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Speaker: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Chair: Fernanda Lemos, RN – member of organization comitee - IMS

Chair: Gabriela Rocco de Sá, RN: Post-graduation in public health, clinical oncology and health management. 15 years of experience in hematology oncology and bone marrow transplantation, (she/her/hers) – Hospital Israelita Albert Einstein

Chair: Tracy King, PhD, MSc, RN – Institute of Haematology, Royal Prince Alfred Hospital

Speaker: Anant Madabhushi, PhD (he/him/his) – Emory University

Co-Chair: Tiffany A. Richards, PhD, ANP-BC AOCNP (she/her/hers) – MD Anderson Cancer Center

Co-Chair: Tracy King, PhD, MSc, RN – Institute of Haematology, Royal Prince Alfred Hospital

Speaker: Jens Hillengass, MD, PhD (he/him/his) – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Speaker: Orla McCourt, PhD – University College London NHS Foundation Trust

Speaker: Donna D. Catamero, ANP-BC – Mount Sinai Hospital

Speaker: Danielle L. Roberts, PA-C (she/her/hers) – Winship Cancer Institute, Emory University

Chair: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Co-Chair: María-Victoria Mateos, MD, PhD – University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain

Speaker: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA

Speaker: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland

Speaker: Madhav V. Dhodapkar, MD, (he/him/his) – Winship Cancer Institute, Emory University, Atlanta, GA, USA

Speaker: Vincent Rajkumar, MD – Mayo Clinic

Speaker: María-Victoria Mateos, MD, PhD – University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain

Panelist: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy

Panelist: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA

Panelist: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland

Panelist: Madhav V. Dhodapkar, MD, (he/him/his) – Winship Cancer Institute, Emory University, Atlanta, GA, USA

Panelist: Vincent Rajkumar, MD – Mayo Clinic

Co-Chair: Charise Gleason, NP-C – Winship Cancer Institute of Emory University

Co-Chair: Orla McCourt, PhD – University College London NHS Foundation Trust

Speaker: Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil

Speaker: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK

Speaker: Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO (she/her/hers) – Cleveland Clinic

Speaker: Rebecca Lu, MS, FNP-C* – The University of Texas MD Anderson Cancer Center

Co-Chair: Natalie Callander, MD – University of Wisconsin

Co-Chair: Sergio Giralt, MD – Memorial Sloan Kettering Cancer Center

Speaker: Verónica González-Calle, MD, PhD (she/her/hers) – Department of Hematology, University Hospital of Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain

Speaker: Jill CORRE, PharmD, PhD (she/her/hers) – Institut Universitaire du Cancer de Toulouse-Oncopole

Speaker: Meletios A. Dimopoulos, MD – National and Kapodistrian University of Athens

Speaker: Tanya Wildes, MD, MSCI (she/her/hers) – University of Nebraska Medical Center/Nebraska Medicine

Speaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Dana-Farber Cancer Institute, Boston, MA, USA

Co-Chair: Niccolo Bolli, MD, PhD – University of Milan

Co-Chair: Michel Delforge, MD/Phd (he/him/his) – University of Leuven, Leuven, Belgium

Speaker: Chaitanya R. Acharya, PhD (he/him/his) – Multiple Myeloma Research Foundation

Speaker: Andrew McPherson, PhD – Memorial Sloan Kettering Cancer Center

Speaker: Ariosto Siqueira Silva, PhD – H. Lee Moffitt Cancer Center and Research Institute

Speaker: Tina Bagratuni, PhD (she/her/hers) – National and Kapodistrian University of Athens

Speaker: Chaitanya R. Acharya, PhD (he/him/his) – Multiple Myeloma Research Foundation

Co-Chair: Monica Morris, MSc, RN – Myeloma UK

Co-Chair: Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO (she/her/hers) – Cleveland Clinic

Speaker: Vincent Rajkumar, MD – Mayo Clinic

Speaker: Sara A. Scott, PharmD, BCOP – Winship Cancer Institute, Emory University

Speaker: Tracy King, PhD, MSc, RN – Institute of Haematology, Royal Prince Alfred Hospital

Panelist: Andrea D. Preston, MRPharmS (Consultant) (she/her/hers) – NHS / Sanius Health

Panelist: Mary Steinbach, DNPli APRN – Huntsman Cancer Institute/University of Utah

Panelist: Jacqui Jagger, RN, BA(Hons), MN(NP) – CCLHD

Panelist: Rahul Banerjee, MD (he/him/his) – Fred Hutchinson Cancer Center

Speaker: Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO (she/her/hers) – Cleveland Clinic

Chair: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Speaker: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Speaker: Fredrik Schjesvold, MD, PhD – Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo

Speaker: Roberto Mina, MD – European Myeloma Network, Italy

Speaker: Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA

Speaker: Luciano J. Costa, MD, PhD – University of Alabama at Birmingham, Birmingham, AL, USA

Panelist: Roberto Mina, MD – European Myeloma Network, Italy

Panelist: Fredrik Schjesvold, MD, PhD – Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo

Panelist: Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA

Panelist: Luciano J. Costa, MD, PhD – University of Alabama at Birmingham, Birmingham, AL, USA

Chair: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra

Co-Chair: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Speaker: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino

Speaker: Ajay K. Nooka, MD, MPH (he/him/his) – Winship Cancer Institute, Emory University School of Medicine

Speaker: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary

Speaker: Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina.

Speaker: Salomon Manier, MD, PhD – Lille University Hospital

Speaker: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Panelist: Hartmut Goldschmidt, MD (he/him/his) – Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)

Panelist: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino

Panelist: Ajay K. Nooka, MD, MPH (he/him/his) – Winship Cancer Institute, Emory University School of Medicine

Panelist: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary

Panelist: Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina.

Panelist: Salomon Manier, MD, PhD – Lille University Hospital

Co-Chair: Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE

Co-Chair: Brian GM Durie – Cedars-SInai Cancer Center, Los Angeles CA 90046

Speaker: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Panelist: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Panelist: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra

Panelist: Ola Landgren, MD, PhD (he/him/his) – University of Miami, Sylvester Comprehensive Cancer Center

Panelist: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Panelist: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Panelist: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra

Discussant: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center

Poster Presenter: Diana Basali, MD – Cleveland Clinic

Discussant: Rafat Abonour, Professor – Indiana University School of Medicine

Poster Presenter: Ulrike Dapunt, MD – Internal Medicine V, GMMG-Study Group at University Hospital Heidelberg, Heidelberg, Germany

Discussant: P.Joy Ho, MBBS DPhil FRACP FRCPA – Institute of Haematology, Royal Prince Alfred Hospital

Poster Presenter: Rahul Banerjee, MD (he/him/his) – Fred Hutchinson Cancer Center

Discussant: Rafat Abonour, Professor – Indiana University School of Medicine

Poster Presenter: Ulrike Dapunt, MD – Internal Medicine V, GMMG-Study Group at University Hospital Heidelberg, Heidelberg, Germany

Discussant: P.Joy Ho, MBBS DPhil FRACP FRCPA – Institute of Haematology, Royal Prince Alfred Hospital

Poster Presenter: Ioannis Ntanasis-Stathopoulos, MD, MSc, PhD – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Discussant: Diana Cirstea

Poster Presenter: Tommer Mark

Poster Presenter: Salomon Manier, MD, PhD – Lille University Hospital

Discussant: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center

Discussant: Rafat Abonour, Professor – Indiana University School of Medicine

Poster Presenter: Patrick Born (he/him/his) – University Leipzig Medical Center, Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, Leipzig, Germany

Discussant: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center

Poster Presenter: Timothy M. Schmidt, MD (he/him/his) – University of Wisconsin

Discussant: Diana Cirstea

Poster Presenter: María-Victoria Mateos, MD, PhD – University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain

Speaker: Laura Rosiñol, Doctor (she/her/hers) – Hospital Clinic de Barcelona

Speaker: Yael C. Cohen, MD (she/her/hers) – Tel- Aviv Sourasky (Ichilov) Medical Center, and Faculty of health Science, Tel Aviv University, Tel Aviv, Israel

Speaker: Gordon Cook, PhD, DSc – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK

Speaker: Ashley Rosko, MD (she/her/hers) – The Ohio State University

Speaker: Rafael Fonseca, MD – Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA

Speaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany

Speaker: Morie A. Gertz, MD, MACP (he/him/his) – Mayo Clinic

Speaker: Heinz Ludwig, MD (he/him/his) – Wilhelminen Cancer Research Institute, c/o Department of Medicine I, Klinik Ottakring

Co-Chair: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Co-Chair: Edvan q. Crusoe, MD, MDc, PhD (he/him/his) – UFBA and Rede D'or Oncologia

Speaker: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Speaker: Edvan q. Crusoe, MD, MDc, PhD (he/him/his) – UFBA and Rede D'or Oncologia

Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University

Speaker: Adam D. Cohen, MD – Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Speaker: Meletios A. Dimopoulos, MD – National and Kapodistrian University of Athens

Panelist: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Panelist: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University

Panelist: Adam D. Cohen, MD – Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

Panelist: Meletios A. Dimopoulos, MD – National and Kapodistrian University of Athens

Speaker: Edvan q. Crusoe, MD, MDc, PhD (he/him/his) – UFBA and Rede D'or Oncologia

Speaker: Edvan q. Crusoe, MD, MDc, PhD (he/him/his) – UFBA and Rede D'or Oncologia

Speaker: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust

Co-Chair: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Chair: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre

Speaker: Jill CORRE, PharmD, PhD (she/her/hers) – Institut Universitaire du Cancer de Toulouse-Oncopole

Speaker: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS (he/him/his) – National University Cancer Institute, Singapore

Speaker: Martin F. Kaiser, MD, FRCP, FRCPath – The Institute of Cancer Research; Royal Marsden Hospital

Speaker: Katja Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany

Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA

Panelist: Angelo Maiolino – Universidade Federal do Rio de Janeiro

Panelist: Jill CORRE, PharmD, PhD (she/her/hers) – Institut Universitaire du Cancer de Toulouse-Oncopole

Panelist: Wee Joo Chng, MB ChB, PhD, FRCP (UK), FRCPath (UK), FAMS (he/him/his) – National University Cancer Institute, Singapore

Panelist: Martin F. Kaiser, MD, FRCP, FRCPath – The Institute of Cancer Research; Royal Marsden Hospital

Panelist: Katja Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany

Chair: Jayr Schmidt, MD (he/him/his) – A.C.Camargo Cancer Center

Speaker: Jayr Schmidt, MD (he/him/his) – A.C.Camargo Cancer Center

Speaker: Susan Bal, MD – University of Alabama at Birmingham

Speaker: Cesar Rodriguez, MD – Icahn School of Medicine at Mount Sinai

Speaker: Rahul Banerjee, MD (he/him/his) – Fred Hutchinson Cancer Center

Panelist: Jayr Schmidt, MD (he/him/his) – A.C.Camargo Cancer Center

Panelist: Susan Bal, MD – University of Alabama at Birmingham

Panelist: Cesar Rodriguez, MD – Icahn School of Medicine at Mount Sinai

Panelist: Rahul Banerjee, MD (he/him/his) – Fred Hutchinson Cancer Center

Speaker: Jayr Schmidt, MD (he/him/his) – A.C.Camargo Cancer Center

Co-Chair: Andrea D. Preston, MRPharmS (Consultant) (she/her/hers) – NHS / Sanius Health

Co-Chair: Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO (she/her/hers) – Cleveland Clinic

Chair: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Chair: Pieter Sonneveld, MD, PhD (he/him/his) – EMN

Speaker: Luciano J. Costa, MD, PhD – University of Alabama at Birmingham, Birmingham, AL, USA

Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Panelist: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Panelist: Michel Delforge, MD/Phd (he/him/his) – University of Leuven, Leuven, Belgium

Co-Chair: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network

Chair: Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil

Speaker: Mehmet K. Samur, PhD – Dana-Farber Cancer Institute

Speaker: P.Joy Ho, MBBS DPhil FRACP FRCPA – Institute of Haematology, Royal Prince Alfred Hospital

Speaker: Marc S. Raab, MD PhD (he/him/his) – Dept. of Medicine V Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

Speaker: Hang Quach, MBBS(Hons) SpecCertOC FRACP FRCPA MD (she/her/hers) – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia

Speaker: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network

Panelist: Pankaj Malhotra, MD – Postgraduate Institute of Medical Education and Research, Chandigarh

Panelist: Mehmet K. Samur, PhD – Dana-Farber Cancer Institute

Panelist: P.Joy Ho, MBBS DPhil FRACP FRCPA – Institute of Haematology, Royal Prince Alfred Hospital

Panelist: Marc S. Raab, MD PhD (he/him/his) – Dept. of Medicine V Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

Panelist: Hang Quach, MBBS(Hons) SpecCertOC FRACP FRCPA MD (she/her/hers) – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia

Co-Chair: Charlotte Pawlyn, PhD, FRCP, FRCPath (she/her/hers) – The Institute of Cancer Research

Co-Chair: Andrzej Jakubowiak

Speaker: Susan Bal, MD – University of Alabama at Birmingham

Speaker: Meletios A. Dimopoulos, MD – National and Kapodistrian University of Athens

Speaker: Nisha S. Joseph, MD – Winship Cancer Institute, Emory University

Speaker: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France

Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Chair: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Speaker: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Speaker: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France

Speaker: Elias K. Mai (he/him/his) – Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

Speaker: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Speaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Dana-Farber Cancer Institute, Boston, MA, USA

Panelist: Thomas Martin, MD – Department of Hematology, University of California at San Francisco, San Francisco, CA, USA

Panelist: Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France

Panelist: Elias K. Mai (he/him/his) – Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

Panelist: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Dana-Farber Cancer Institute, Boston, MA, USA

Co-Chair: Meral Beksac, MD (she/her/hers) – Istinye University

Co-Chair: Michael O'Dwyer, MD – University of Galway, Galway, Ireland

Speaker: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary

Speaker: Yael C. Cohen, MD (she/her/hers) – Tel- Aviv Sourasky (Ichilov) Medical Center, and Faculty of health Science, Tel Aviv University, Tel Aviv, Israel

Speaker: Myo Htut, MD – City of Hope Comprehensive Cancer Center

Speaker: Yael C. Cohen, MD (she/her/hers) – Tel- Aviv Sourasky (Ichilov) Medical Center, and Faculty of health Science, Tel Aviv University, Tel Aviv, Israel

Speaker: Marc S. Raab, MD PhD (he/him/his) – Dept. of Medicine V Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

Co-Chair: Manoj Bhasin, PhD – Emory University

Co-Chair: Francesco Maura, MD – University of Miami

Speaker: Dipal Mehta, MBBS MRCP (he/him/his) – UCL Cancer Institute, University College London

Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Speaker: Wenqiang Yan, MD – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Speaker: Selma Bekri, PhD (she/her/hers) – Tisch Cancer Institute, Icahn School of Medicine at Mt. Sinai

Speaker: Elizabeth D. Lightbody, PhD – Dana-Farber Cancer Institute

Co-Chair: Steven P. Treon, MD, PhD, FACP, FRCP (he/him/his) – Dana-Farber Cancer Institute, Bing Center for Waldenstroms macroglobulinemia

Co-Chair: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University

Speaker: Roberto Garcia-Vicente, MSc (he/him/his) – Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain

Speaker: Surbhi Sidana, surbhi.sidana@stanford.edu – Stanford University

Speaker: Ioannis V. Kostopoulos, MSc, PhD (he/him/his) – Flow Cytometry Unit, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece

Speaker: Tadeusz Kubicki, MD, PhD – University of Chicago

Speaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Dana-Farber Cancer Institute, Boston, MA, USA

Chair: Noopur Raje, MD – Massachusetts General Hospital Cancer Center

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Ajai Chari, MD, PhD – University of California, San Francisco

Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Speaker: Paola Neri, MD, PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary

Speaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Speaker: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Panelist: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC

Panelist: Ajai Chari, MD, PhD – University of California, San Francisco

Panelist: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Panelist: Paola Neri, MD, PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary

Panelist: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany

Speaker: Ramon Garcia Sanz, PhD (he/him/his) – Dept. of Hematology, University Hospital of Salamanca

Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Speaker: Surbhi Sidana, surbhi.sidana@stanford.edu – Stanford University

Speaker: Hira Mian, MD, MSc, FRCPC (she/her/hers) – McMaster University, Hamilton, Ontario, Canada

Co-Chair: Kenneth C. Anderson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Niccolo Bolli, MD, PhD – University of Milan

Panelist: Niccolo Bolli, MD, PhD – University of Milan

Speaker: Jose Angel Martinez-Climent, MD PhD – University of Navarra, Center for Applied Medical Research, Department of Hematology, Clinica Universidad de Navarra Cancer Center, School of Medicine

Panelist: Jose Angel Martinez-Climent, MD PhD – University of Navarra, Center for Applied Medical Research, Department of Hematology, Clinica Universidad de Navarra Cancer Center, School of Medicine

Speaker: Josefine Krüger, MD – Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Panelist: Josefine Krüger, MD – Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Speaker: Sara Taranto, PhD (she/her/hers) – ASST Spedali Civili di Brescia

Panelist: Sara Taranto, PhD (she/her/hers) – ASST Spedali Civili di Brescia

Co-Chair: Leif Bergsagel, MD – Mayo Clinic Arizona

Co-Chair: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK

Discussant: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Speaker: Saad Z. Usmani, MD MBA – Memorial Sloan Kettering Cancer Center

Discussant: Noopur Raje, MD – Massachusetts General Hospital Cancer Center

Speaker: Kylee Maclachlan, MBChB, PhD – Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA

Discussant: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Speaker: Romanos Sklavenitis-Pistofidis, MD, PhD – Dana-Farber Cancer Institute

Discussant: María-Victoria Mateos, MD, PhD – University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain

Speaker: Ashraf Z. Badros, MD – The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD, USA

Discussant: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Speaker: Aurore Perrot, MD, PhD – CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France

Speaker: Jesus G. Berdeja, MD – Tennessee Oncology

Speaker: Natalia P. Schütz (she/her/hers) – Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

Speaker: Jorge J. Castillo, MD – Bing Center for Waldenstrom Macroglobulinemia

Speaker: Prashant Kapoor, MD – Mayo Clinic

Co-Chair: Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Nicole Gormley, MD – U.S. Food and Drug Administration

Speaker: Bindu Kanapuru, MD – Food and Drug Administration

Speaker: Edward Laane, MD, PhD (he/him/his) – Tartu University

Speaker: Michal Zwiewka, MD – Paul-Ehrlich-Institut

Speaker: Nicole Gormley, MD – U.S. Food and Drug Administration

Speaker: Bindu Kanapuru, MD – Food and Drug Administration

Speaker: Edward Laane, MD, PhD (he/him/his) – Tartu University

Speaker: Michal Zwiewka, MD – Paul-Ehrlich-Institut

Co-Chair: Tanya Wildes, MD, MSCI (she/her/hers) – University of Nebraska Medical Center/Nebraska Medicine

Co-Chair: Enrique M. Ocio, MD, PhD – Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain

Speaker: María-Victoria Mateos, MD, PhD – University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain

Speaker: Bhagirathbhai Dholaria, MBBS (he/him/his) – Vanderbilt-Ingram Cancer Center, Nashville, TN

Speaker: Doris K. Hansen, MD – Moffiitt Cancer Center

Speaker: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University

Speaker: Binod Dhakal, MD, MS – Medical College of Wisconsin, Milwaukee, WI, USA

Co-Chair: Jens Hillengass, MD, PhD (he/him/his) – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Co-Chair: Nicola Giuliani, MD, PhD – Department of Medicine and Surgery, University of Parma, Parma, Italy

Speaker: Joaquín Martínez-López – Hospital 12 de Octubre, Madrid

Speaker: Joshua Gustine, MD – Massachusetts General Hospital

Speaker: Holly Lee, MD – University of Calgary

Speaker: Marco Talarico, MD – Università di Bologna - IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli"

Speaker: Panagiotis Malandrakis, MD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Discussant: Efstathios Kastritis, MD, PhD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Poster Presenter: Eric M. Jurgens, MD – Department of Medicine, Memorial Sloan Kettering Cancer Center

Discussant: Noa Biran, MD (she/her/hers) – Hackensack Meridian Health School of Medicine; The John Theurer Cancer Center

Poster Presenter: Attaya Suvannasankha, MD – Indiana University Simon Cancer Center and Roudebush VAMC, Indianapolis, IN, USA

Discussant: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.

Poster Presenter: Kylee Maclachlan, MBChB, PhD – Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA

Poster Presenter: yijie wang – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

Discussant: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital

Discussant: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.

Poster Presenter: Borja Puertas (he/him/his) – Hospital Universitario de Salamanca

Discussant: Noa Biran, MD (she/her/hers) – Hackensack Meridian Health School of Medicine; The John Theurer Cancer Center

Poster Presenter: Nathan Martin, PhD (he/him/his) – Bristol Myers Squibb

Discussant: Efstathios Kastritis, MD, PhD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Poster Presenter: Oumaima Jaouadi, Ph.D – Melvin and Bren Simon Comprehensive Cancer Center

Discussant: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital

Poster Presenter: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University

Discussant: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital

Poster Presenter: Natalia Buenache – Hospital Universitario 12 Octubre

Discussant: Noa Biran, MD (she/her/hers) – Hackensack Meridian Health School of Medicine; The John Theurer Cancer Center

Poster Presenter: Cecilia Bonolo de Campos, MSc PhD – Princess Margaret Cancer Center - UHN

Discussant: Efstathios Kastritis, MD, PhD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Poster Presenter: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Speaker: Aurore Perrot, MD, PhD – CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France

Speaker: Karthik Ramasamy, MBBS FRCP FRCPath PhD – University of Oxford and Oxford University Hospitals NHS FT

Speaker: Mala Shanmugam, MS, PhD (she/her/hers) – Winship Cancer Institute, Emory University

Speaker: Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona

Speaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute

Speaker: Lawrence H. Boise, PhD – Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA, USA

Speaker: Mariateresa Fulciniti, PhD – Dana-Farber Cancer Institute

Speaker: Angela Dispenzieri, MD – Mayo Clinic Rochester

Chair: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France

Speaker: Mohamad Mohty, MD, PhD – Sorbonne University, Saint-Antoine Hospital, AP-HP INSERM UMRs 938, Paris, France

Speaker: Donna E. Reece, MD (she/her/hers) – University Health Network, Princess Margaret Cancer Centre

Speaker: Craig Emmitt Cole, MD (he/him/his) – Karmanos Cancer Institute-Wayne State and Michigan State University

Speaker: Cyrille Touzeau, MD, PhD – CHU Nantes

Panelist: Donna E. Reece, MD (she/her/hers) – University Health Network, Princess Margaret Cancer Centre

Panelist: Craig Emmitt Cole, MD (he/him/his) – Karmanos Cancer Institute-Wayne State and Michigan State University

Panelist: Cyrille Touzeau, MD, PhD – CHU Nantes

Co-Chair: Sundar Jagannath, MD, FASCO (he/him/his) – Mount Sinai Medical Center, New York, NY, USA

Co-Chair: Robert Z. Orlowski, PhD, MD (he/him/his) – The University of Texas MD Anderson Cancer Center

Speaker: Jordan M. Schecter, MD (he/him/his) – Janssen R&D, Raritan, NJ, USA

Panelist: Jordan M. Schecter, MD (he/him/his) – Janssen R&D, Raritan, NJ, USA

Speaker: Joanna Opalinska, n/a – GlaxoSmithKline

Panelist: Joanna Opalinska, n/a – GlaxoSmithKline

Speaker: Nathan Martin, PhD (he/him/his) – Bristol Myers Squibb

Panelist: Nathan Martin, PhD (he/him/his) – Bristol Myers Squibb

Speaker: Zandra K. Klippel, MD (she/her/hers) – Sanofi

Panelist: Zandra K. Klippel, MD (she/her/hers) – Sanofi

Speaker: Isabel Perez Cruz, PhD – Pfizer

Panelist: Isabel Perez Cruz, PhD – Pfizer

Co-Chair: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center

Co-Chair: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany

Speaker: Teng Fang, PhD student – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.

Speaker: Mariateresa Fulciniti, PhD – Dana-Farber Cancer Institute

Speaker: Sae Matsuoka, MD (she/her/hers) – Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan

Speaker: Paula Rodriguez-Marquez, PhD (she/her/hers) – Hemato-Oncology Program. CIMA Universidad de Navarra. IdiSNA

Co-Chair: Javier de la Rubia, Prof. Dr. (he/him/his) – Hematology Department, University Hospital La Fe

Co-Chair: Cyrille Touzeau, MD, PhD – CHU Nantes

Speaker: Meletios A. Dimopoulos, MD – National and Kapodistrian University of Athens

Speaker: Neha Korde, MD – Memorial Sloan Kettering Cancer Center

Speaker: Sheeba Thomas, MD (she/her/hers) – MD Anderson Cancer Center

Speaker: Oliver M. Tomkins, MRCP FRCPath – University College London Hospitals NHS Foundation Trust

Speaker: Christopher Parrish, PhD (he/him/his) – Leeds Teaching Hospitals NHS Trust

Co-Chair: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA

Co-Chair: Brian A. Walker, PhD (he/him/his) – Indiana University

Speaker: Luciano J. Costa, MD, PhD – University of Alabama at Birmingham, Birmingham, AL, USA

Speaker: Shebli Atrash, MD – Levine Cancer Institute

Speaker: Abel Costa, MD – D'Or Institute for Research and Education

Speaker: Cyrille Touzeau, MD, PhD – CHU Nantes

Speaker: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada

Co-Chair: Damian Green, MD (he/him/his) – Sylvester Comprehensive Cancer Center/University of Miami

Co-Chair: Mehmet K. Samur, PhD – Dana-Farber Cancer Institute

Speaker: Marta Larrayoz, PhD (she/her/hers) – University of Navarra

Speaker: Phaik Ju Teoh, PhD – Cancer Science Institute of Singapore, National University of Singapore

Speaker: David Fandrei, MSc – University Leipzig Medical Center, Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, Leipzig, Germany

Speaker: Lixin Gong, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China. – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Speaker: Qiang Wang (he/him/his) – Houston Methodist Research Institute

Chair: Kenneth C. Anderson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Co-Chair: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Speaker: Saad Z. Usmani, MD MBA – Memorial Sloan Kettering Cancer Center

Speaker: Bruno Paiva, PhD – Clínica Universidad de Navarra (CUN), Centro de Investigación Médica Aplicada (CIMA LAB Diagnostics), IDISNA, CIBERONC

Speaker: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada

Speaker: Ashley Rosko, MD (she/her/hers) – The Ohio State University

Speaker: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Panelist: Noemi Puig, MD, PhD – Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL)

Panelist: Saad Z. Usmani, MD MBA – Memorial Sloan Kettering Cancer Center

Panelist: Bruno Paiva, PhD – Clínica Universidad de Navarra (CUN), Centro de Investigación Médica Aplicada (CIMA LAB Diagnostics), IDISNA, CIBERONC

Panelist: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada

Panelist: Ashley Rosko, MD (she/her/hers) – The Ohio State University